FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2764323500> ?p ?o ?g. }

• W2764323500 endingPage "19468" @default.
• W2764323500 startingPage "19458" @default.
• W2764323500 abstract "Metabolic deceleration in pancreatic β-cells is associated with inhibition of glucose-induced insulin secretion (GIIS), but only in the presence of intermediate/submaximal glucose concentrations. Here, we used acute metformin treatment as a tool to induce metabolic deceleration in INS1 (832/13) β-cells, with the goal of identifying key pathways and metabolites involved in GIIS. Metabolites and pathways previously implicated as signals for GIIS were measured in the cells at 2–25 mm glucose, with or without 5 mm metformin. We defined three criteria to identify candidate signals: 1) glucose-responsiveness, 2) sensitivity to metformin-induced inhibition of the glucose effect at intermediate glucose concentrations, and 3) alleviation of metformin inhibition by elevated glucose concentrations. Despite the lack of recovery from metformin-induced impairment of mitochondrial energy metabolism (glucose oxidation, O2 consumption, and ATP production), insulin secretion was almost completely restored at elevated glucose concentrations. Meeting the criteria for candidates involved in promoting GIIS were the following metabolic indicators and metabolites: cytosolic NAD+/NADH ratio (inferred from the dihydroxyacetone phosphate:glycerol-3-phosphate ratio), mitochondrial membrane potential, ADP, Ca2+, 1-monoacylglycerol, diacylglycerol, malonyl-CoA, and HMG-CoA. On the contrary, most of the purine and nicotinamide nucleotides, acetoacetyl-CoA, H2O2, reduced glutathione, and 2-monoacylglycerol were not glucose-responsive. Overall these results underscore the significance of mitochondrial energy metabolism-independent signals in GIIS regulation; in particular, the candidate lipid signaling molecules 1-monoacylglycerol, diacylglycerol, and malonyl-CoA; the predominance of KATP/Ca2+ signaling control by low ADP·Mg2+ rather than by high ATP levels; and a role for a more oxidized state (NAD+/NADH) in the cytosol during GIIS that favors high glycolysis rates. Metabolic deceleration in pancreatic β-cells is associated with inhibition of glucose-induced insulin secretion (GIIS), but only in the presence of intermediate/submaximal glucose concentrations. Here, we used acute metformin treatment as a tool to induce metabolic deceleration in INS1 (832/13) β-cells, with the goal of identifying key pathways and metabolites involved in GIIS. Metabolites and pathways previously implicated as signals for GIIS were measured in the cells at 2–25 mm glucose, with or without 5 mm metformin. We defined three criteria to identify candidate signals: 1) glucose-responsiveness, 2) sensitivity to metformin-induced inhibition of the glucose effect at intermediate glucose concentrations, and 3) alleviation of metformin inhibition by elevated glucose concentrations. Despite the lack of recovery from metformin-induced impairment of mitochondrial energy metabolism (glucose oxidation, O2 consumption, and ATP production), insulin secretion was almost completely restored at elevated glucose concentrations. Meeting the criteria for candidates involved in promoting GIIS were the following metabolic indicators and metabolites: cytosolic NAD+/NADH ratio (inferred from the dihydroxyacetone phosphate:glycerol-3-phosphate ratio), mitochondrial membrane potential, ADP, Ca2+, 1-monoacylglycerol, diacylglycerol, malonyl-CoA, and HMG-CoA. On the contrary, most of the purine and nicotinamide nucleotides, acetoacetyl-CoA, H2O2, reduced glutathione, and 2-monoacylglycerol were not glucose-responsive. Overall these results underscore the significance of mitochondrial energy metabolism-independent signals in GIIS regulation; in particular, the candidate lipid signaling molecules 1-monoacylglycerol, diacylglycerol, and malonyl-CoA; the predominance of KATP/Ca2+ signaling control by low ADP·Mg2+ rather than by high ATP levels; and a role for a more oxidized state (NAD+/NADH) in the cytosol during GIIS that favors high glycolysis rates." @default.
• W2764323500 created "2017-10-20" @default.
• W2764323500 creator A5001442165 @default.
• W2764323500 creator A5036118278 @default.
• W2764323500 creator A5045603459 @default.
• W2764323500 creator A5051590202 @default.
• W2764323500 creator A5084691810 @default.
• W2764323500 creator A5087846740 @default.
• W2764323500 date "2017-11-01" @default.
• W2764323500 modified "2023-10-18" @default.
• W2764323500 title "Identification of the signals for glucose-induced insulin secretion in INS1 (832/13) β-cells using metformin-induced metabolic deceleration as a model" @default.
• W2764323500 cites W1499384204 @default.
• W2764323500 cites W1525779234 @default.
• W2764323500 cites W1554141820 @default.
• W2764323500 cites W1572077460 @default.
• W2764323500 cites W1598254642 @default.
• W2764323500 cites W1786380341 @default.
• W2764323500 cites W1865964651 @default.
• W2764323500 cites W1944929529 @default.
• W2764323500 cites W1973045246 @default.
• W2764323500 cites W1980111447 @default.
• W2764323500 cites W1995069275 @default.
• W2764323500 cites W1997226402 @default.
• W2764323500 cites W2006454401 @default.
• W2764323500 cites W2012442095 @default.
• W2764323500 cites W2017304883 @default.
• W2764323500 cites W2020554400 @default.
• W2764323500 cites W2022446120 @default.
• W2764323500 cites W2030255635 @default.
• W2764323500 cites W2040470654 @default.
• W2764323500 cites W2047516613 @default.
• W2764323500 cites W2056860785 @default.
• W2764323500 cites W2058736493 @default.
• W2764323500 cites W2062188766 @default.
• W2764323500 cites W2062231784 @default.
• W2764323500 cites W2063779341 @default.
• W2764323500 cites W2068009433 @default.
• W2764323500 cites W2068527308 @default.
• W2764323500 cites W2074092708 @default.
• W2764323500 cites W2075009646 @default.
• W2764323500 cites W2077032611 @default.
• W2764323500 cites W2079795968 @default.
• W2764323500 cites W2080001569 @default.
• W2764323500 cites W2080863876 @default.
• W2764323500 cites W2087613739 @default.
• W2764323500 cites W2088160164 @default.
• W2764323500 cites W2108781675 @default.
• W2764323500 cites W2109069544 @default.
• W2764323500 cites W2112654061 @default.
• W2764323500 cites W2121990555 @default.
• W2764323500 cites W2122341467 @default.
• W2764323500 cites W2133162233 @default.
• W2764323500 cites W2134907909 @default.
• W2764323500 cites W2140656074 @default.
• W2764323500 cites W2142354305 @default.
• W2764323500 cites W2142510033 @default.
• W2764323500 cites W2153134360 @default.
• W2764323500 cites W2166949410 @default.
• W2764323500 cites W2168180935 @default.
• W2764323500 cites W2176847545 @default.
• W2764323500 cites W2236591107 @default.
• W2764323500 cites W2340621143 @default.
• W2764323500 cites W2403578638 @default.
• W2764323500 cites W2508942015 @default.
• W2764323500 cites W2522799028 @default.
• W2764323500 cites W2525160505 @default.
• W2764323500 cites W2559894696 @default.
• W2764323500 cites W2570569124 @default.
• W2764323500 cites W2592635641 @default.
• W2764323500 doi "https://doi.org/10.1074/jbc.m117.808105" @default.
• W2764323500 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5702682" @default.
• W2764323500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28972173" @default.
• W2764323500 hasPublicationYear "2017" @default.
• W2764323500 type Work @default.
• W2764323500 sameAs 2764323500 @default.
• W2764323500 citedByCount "19" @default.
• W2764323500 countsByYear W27643235002018 @default.
• W2764323500 countsByYear W27643235002019 @default.
• W2764323500 countsByYear W27643235002020 @default.
• W2764323500 countsByYear W27643235002021 @default.
• W2764323500 countsByYear W27643235002022 @default.
• W2764323500 countsByYear W27643235002023 @default.
• W2764323500 crossrefType "journal-article" @default.
• W2764323500 hasAuthorship W2764323500A5001442165 @default.
• W2764323500 hasAuthorship W2764323500A5036118278 @default.
• W2764323500 hasAuthorship W2764323500A5045603459 @default.
• W2764323500 hasAuthorship W2764323500A5051590202 @default.
• W2764323500 hasAuthorship W2764323500A5084691810 @default.
• W2764323500 hasAuthorship W2764323500A5087846740 @default.
• W2764323500 hasBestOaLocation W27643235001 @default.
• W2764323500 hasConcept C126322002 @default.
• W2764323500 hasConcept C134018914 @default.
• W2764323500 hasConcept C170493617 @default.
• W2764323500 hasConcept C17093226 @default.
• W2764323500 hasConcept C181199279 @default.
• W2764323500 hasConcept C185592680 @default.
• W2764323500 hasConcept C195794163 @default.
• W2764323500 hasConcept C2777391703 @default.

• next